Introduction
Epidermal keratinocytes which represent a major constituent of the skin, produce various cytokines such as transforming growth factor (TGF) a, tumor necrosis factor (TNF) a, interferon g, granulocyte-macrophage colony-stimulating factor (GMCSF), interleukin (IL)-1, IL-6 and IL-8 (Kupper, 1990) . Of these, IL-6 is interesting in that it is a multifunctional cytokine involved in immune and in¯ammatory responses, which stimulates proliferation of both epidermal cells and lymphocytes (Kishimoto, 1989; Krueger et al., 1991; Turksen et al., 1992) . These properties make it a possible key component of the interaction between the epidermis and the immune system in in¯ammatory and auto-immune skin diseases such as psoriasis (Grossman et al., 1989; Neuner et al., 1991) and lichen planus (Yamamoto and Osaki, 1995) . In these diseases, T-cell in®ltrates are frequently observed and thought to play an important role in sustaining a chronic in¯ammatory process. IL-4, a product of T-helper cells, has been shown to up-regulate IL-6 production in endothelial cells (Howells et al., 1991) , in ®broblasts (Doucet et al., 1998; Feghali et al., 1992) and in keratinocytes (Derocq et al., 1994; Kupper et al., 1989) .
In recent years, important eorts have been made to de®ne the intracellular signaling cascade in cells that mediate the in¯ammatory process. Several groups have made of the mitogen activated protein kinase (MAPK) superfamily the center of the intracellular signaling due to their consistent activation by pro-in¯ammatory cytokines, and their role in nuclear signaling. This superfamily includes, among others, the extracellular signal response kinases (ERK), c-jun N-terminal kinases (JNK), and the p38 MAPK family of kinases. Interest in the p38 MAPK family has been particularly intense following the discovery of p38 inhibitors that block in¯ammatory response in vivo (Badger et al., 1996; Jackson et al., 1998; Lee et al., 1994) . Four genes encode the known members of the p38 MAPK family, p38 MAPK a, b, g and d Wang et al., 1997) . Dual phosphorylation of the TGY motif in p38 MAPK a, b, g and d is catalysed by the kinase MKK6 and is required for p38 MAPK activation (Enslen et al., 1998) . With the exception of p38 MAPK b, p38 MAPK may also be activated by MKK3 (Enslen et al., 1998) . p38 MAPK a, b, g and d phosphorylate activating transcription factor-2 (ATF-2) Kumar et al., 1997) . The Rho family GTPases, Rac1 and Cdc42 (Bagrodia et al., 1995; Coso et al., 1995; Minden et al., 1995; Olson et al., 1995; Zhang et al., 1995) and the STE20-related protein kinase PAK1 (Zhang et al., 1995) , PAK3 (Bagrodia et al., 1995) and GC-kinase (Pombo et al., 1995) have been implicated in the p38 MAPK and JNK signaling pathways.
The widely used pyridinylimidazol compounds SB203580 and SB202190, are nearly equipotent inhibitors of p38 MAPK a and b but do not inhibit p38 MAPK g or d Kumar et al., 1997; Stein et al., 1997; Wang et al., 1997) . They inhibit production of TNFa and IL-1 by LPS-stimulated human monocyte at the translational level (Lee and Young, 1996) and IL-6 production by TNFa-stimulated murine ®brosarcoma L929 cells at the transcriptional level (Beyaert et al., 1996; Vanden Berghe et al., 1998) . Involvement of p38 MAPK in IL-6 production has been described in human osteoblastic cells stimulated by TNFa (Blanque et al., 1997) and in human lung ®broblast stimulated by IL-1b (Ridley et al., 1997) .
After binding of IL-4 to its receptor, tyrosine phosphorylation of several proteins, including IL-4R, p170 IRS-2, members of the JAK family and STAT6 (for review see Chomarat and Banchereau, 1997 ) is observed. However, in lymphocytes IL-4 fails to activate component of the Ras, MAP kinase or SAPK pathways (Foltz et al., 1997; Welham et al., 1995) . In keratinocytes we have previously described that the ERK pathway was activated in response to IL-4 (Wery et al., 1996) .
Here, we demonstrate for the ®rst time that IL-4 induces the activation of p38 MAPK in keratinocytes. In the present study, we also demonstrate the link between IL-4 receptor and p38 MAPK, mediated by Rac/Cdc42/ PAK pathway. We have therefore investigated the eect of speci®c inhibitors of ERK and of p38 MAPK on the induction of IL-6 production stimulated by IL-4. Our results clearly indicate that p38 MAPK is implicated in the stabilization of IL-6 mRNA.
Results

IL-4 activates the p38 MAPK signal transduction pathway
We have previously reported that IL-4 activates MAP kinase in keratinocytes. In order to investigate whether p38 MAPK could be also activated in response to IL-4, p38 MAPK was precipitated from cellular extracts with GST-ATF-2 fusion protein coupled to GSH-Sepharose beads. The p38 MAPK activity was determined in this complex by measuring the phosphorylation of ATF-2. As shown in Figure 1a , we observed a marked increase in p38 MAPK activity which reached a maximum (sixfold) after 30 min of stimulation with IL-4. Under the same conditions, when GST-c-jun was used instead of GST-ATF-2, no increase of phosphorylation of GST-c-jun was observed, indicating that JNK is not activated by IL-4 ( Figure 1b) . As p38 MAPK is activated by dual phosphorylation on tyrosine and threonine residues, the p38 MAPK activation was also monitored by anti phosphotyrosine Western blot. As shown in Figure 1c , IL-4 stimulation led to a marked and transient phosphorylation of p38 MAPK.
It has been shown that PAK and its upstream regulators Rac and Cdc42, members of the Ras superfamily of small GTP-binding proteins, coupled to and regulated the activity of p38 MAPK. Rac and Cdc42 cycle between a GDP-bound inactive state and a GTP-bound active state. Upon binding to GTP, Rac and Cdc42 interact with and activate downstream eectors such as WASP (Aspenstrom et al., 1996; Symons et al., 1996) and PAK (Obermeier et al., 1998) . To determine further that IL-4 activates the signaling pathway leading to p38 MAPK activation, we examined the activation of the upstream activators.
To develop an assay for Rac and Cdc42 activation, we took advantage of the fact that WASP and PAK interact only with the GTP-bound form of Rac and Cdc42. Therefore, a GST-CRIB of PAK was used to anity precipitate cellular GTP bound form of Rac from cellular extracts stimulated or not by IL-4. As shown in Figure 2a , virtually no bound Rac was detected in cellular extracts from serum-starved cells whereas the amount of Rac associated with GST-CRIB of PAK increased after 15 min of stimulation with IL-4, and remained for at least 1 h. To further investigate if Cdc42 was also activated in the same conditions a GST-CRIB of WASP was used. As illustrated in Figure 2b , IL-4 treatment of the cells strongly enhanced the amount of Cdc42 able to bind to GST-CRIB of WASP. These results indicate that both Rac and Cdc 42 are activated by IL-4 stimulation. PAK family members have been shown to phosphorylate in vitro histone H4 and Myelin Basic Protein (MBP). To examine whether PAK was activated by IL-4, PAK was immunoprecipitated from cell lysates and an in vitro immunokinase assay was performed using MBP as substrate. As illustrated in Figure 2c , we observed a transient activation of PAK which peaked at 15 min with a threefold enhancement of MBP phosphorylation. Taken together, the results described above show for the ®rst time that in keratinocytes, IL-4 activates Rac and Cdc42 pathways, leading to PAK and p38 MAPK activation.
p38 MAPK pathway is involved in IL-6 production p38 MAPK is an important mediator of stress-induced gene expression. Treatment of keratinocytes by IL-4 induced production of IL-6 (Derocq et al., 1994) . We therefore investigated whether p38 MAPK could be implicated in this regulation. For this purpose, we examined the eect of a highly speci®c inhibitor of p38 MAPK, SB203580 on IL-6 production stimulated with IL-4 in keratinocytes.
As shown in Figure 3 , IL-4 induced a time dependent production of IL-6 which was clearly detectable after 16 h of IL-4 stimulation. Pretreatment of cells with SB203580 for 1 h prior to IL-4 stimulation led to a *fourfold inhibition of IL-6 production. When the same experiment was performed in the presence of SB202474, a functionally inactive analog of SB203580 (Lee et al., 1994) , no signi®cant inhibition of IL-6 production was observed. The speci®c inhibitor of MEK, PD098059 (Alessi et al., 1995) , did not inhibit the IL-4-induced IL-6 production, indicating that the p38 MAP kinase inhibitory eect by SB203580 is speci®c. This result strongly suggested that p38 MAPK pathway might be implicated in the regulation of IL-6 expression.
Effects of IL-4 and SB203580 on IL-6 transcription
Several regulatory elements such as AP-1, 5'C/EBPb, 3'C/EBPb and NF-kB have been identi®ed within the human IL-6 promoter region. For the identi®cation of the IL-4 induced regulatory elements, we prepared double-stranded oligonucleotides as shown in Figure  4a . The C/EBPb (158 to 7142) oligonucleotide contained the 5'C/EBPb binding element and the IL6kB (775 to 760) oligonucleotide contained the NFkB and RB-Jk binding elements. EMSA was carried out using nuclear extracts from A431 cells, that had been either unstimulated or stimulated with IL-4 for 10 min. As shown in Figure 4c , when the C/EBPb oligonucleotide was used as a probe, a broad band was detected in unstimulated cells (lanes 1 and 2). This band was completely supershifted by addition of anti C/EBPb antibody (lane 3).
When the 32 P-labeled IL-6kB oligonucleotide was incubated with the nuclear extracts obtained from IL-4 stimulated A431 cells, we detected ®ve complexes (C1 ± C5) ( Figure 4d ). Speci®c migrating bands (C1, C2 and C4) were observed both in unstimulated and in IL-4-stimulated nuclear extracts (lanes 1 and 2). Supershift experiments indicated that C2 and C4 were p50/p50 NF-kB homodimers and p50/p65 heterodimers respectively (lanes 4 and 5). The C1 complex was speci®cally abolished by the addition of unlabeled HES (Drosophila hairy enhancer of split) oligonucleotide (lane 6) which contained the RBP-Jk consensus element ( Figure  4b ) (Plaisance et al., 1997) , indicating that C1 correspond to the RBP-Jk containing complex. We were unable to characterize the C3 complex.
In addition to these bands, a new slower migrating band, C5, was detected with the induced nuclear extract ( Figure 4d , lane 2). This complex was super- (0) or stimulated with 50 ng/ml IL-4 as indicated. Rac-GTP (a) or Cdc42-GTP (b) were pulled down from cell lysates using GST-CRIB of PAK (a) or GST-CRIB of WASP (b). After several washings, the bound proteins were visualized by Western blotting with a polyclonal antibody against Rac (a) and Cdc42 (b). Lower panels in a and b show total amount of Rac and Cdc42 in 4% of total extract. Activation of PAK by IL-4 (c) in vitro kinase assay were performed using immunoprecipitated PAK as a kinase with MBP as substrate. The kinase reactions were stopped by adding SDS sample buer and analysed by SDS ± PAGE. Substrate phosphorylation was detected by autoradiography shifted with an anti STAT6 antibody (lane 3), indicating that STAT6, whose consensus binding site is TTC(N) 4 GAA is able to interact with IL-6kB oligonucleotide containing a TTC(N) 4 GAG element. It has often been described that adjacently bound transcriptional factors that functionally cooperate to activate transcription also functionally associate to some extent either in the presence or in absence of their cognate DNA elements (Herschlag and Johnson, 1993; Ptashne and Gann, 1997) . We therefore investigated the putative interactions between C/EBP with either STAT6 and/or NF-kB and STAT6 with NF-kB, on the 5'C/EBP or IL-6kB element respectively. Supershift experiments indicated that none of these interactions could be detected. For analysis of the functional signi®cance of C/ EBPb, NF-kB and STAT6 binding, we used two human IL-6 promoter-luciferase reporter plasmid (p1168huIL-6P-luc and p234huIL-6P-luc contain the 71168 to +10 and 7234 to +10 human IL-6 promoter regions respectively). In order to eliminate both the low transient eciency of transfection and the variability of isolated clones we used stable pools of transfectants. No signi®cant changes were detected in the rate of luciferase expression after IL-4 treatment with these two plasmids (data not shown). IL-6kB motif is critical for the induction of IL-6 promoter (Miyazawa et al., 1998; Plaisance et al., 1997) and contains a putative STAT6 binding sequence overlapping both RBP-Jk and NF-kB binding sequences. It has been already described that STAT6 factor could act as a transcriptional repressor, when the STAT binding site overlaps with NF-kB (Bennett et al., 1997) . EMSA analysis has indicated that STAT6 was the only transcription factor clearly induced by IL-4 and able to bind to the IL-6kB motif in an inducible manner. We therefore have introduced mutations in RBP-Jk, NFkB and STAT6 binding sites and with none of these mutated promoters, we observed an increase in luciferase expression after IL-4 stimulation (data not shown). These results indicated that, whereas transcription factors bound to the IL-6 promoter are activated by IL-4, the regulation of IL-4 induced IL-6 expression may not reside solely at the transcriptional level.
IL-4 stabilizes the IL-6 mRNA
To investigate the mechanism whereby p38 MAP kinase was implicated in IL-6 production, stability of IL-6 mRNA was studied in an RNAse protection analysis. As shown in Figure 5a , stimulation of A431 cells by IL-4 induced a time-dependent increase of IL-6 mRNA expression. SB203580 signi®cantly reduced IL-6 mRNA levels, whereas pretreatment by SB202474 did not signi®cantly modify the IL-6 mRNA expression. Of note, PD098059 appears to enhance IL-6 mRNA expression, whether this really re¯ects a role of the ERK pathway in this regulation is currently under investigation. To determine whether IL-4 acts at the level of the IL-6 mRNA degradation, we carried out mRNA stability assays. A431 cells were stimulated with IL-4 for 5 h with or without inhibitors to express IL-6 mRNA. Then either actinomycin D, an inhibitor of overall gene transcription, was added. Total mRNA was isolated following various time periods after addition of actinomycin D and examined for the presence of IL-6 by RNAse protection analysis. A representative result is shown in Figure 5b . Virtually no modi®cation of IL-6 mRNA level was observed even after 1 h of actinomycin D treatment in IL-4-stimulated cells. SB203580 dramatically reduced the half-life of IL-6 mRNA (10 min versus 60 min in control, data not shown), whereas SB202474 and PD098059 did not signi®cantly modify the steady-state level of IL-6 mRNA. Altogether, these results indicate that activated p38 MAPK is involved in IL-6 synthesis by stabilizing the IL-6 mRNA.
Discussion
In the present study, we show that stimulation of keratinocytes by IL-4 leads to activation of p38 MAPK pathway but not the SAPK1/JNK pathway. Experiments using the speci®c inhibitor of p38 MAPK show that activation of p38 MAPK is required for IL-4 mediated IL-6 expression. Our present study also shows that Rac, Cdc42 and PAK are activated, suggesting that they may be mediators in the p38 MAPK activation pathway downstream of the IL-4R. Our results also indicated that IL-4 mediated IL-6 regulation is obviously not at the transcriptional level but indicated that this regulation occurs through a stabilization of the mRNA encoding for IL-6. Using hematopoietic cell lines, previous observations have indicated that IL-4 was unable to mediate a p38 MAPK activation (Foltz et al., 1997) . The results presented here are consistent with our previous ®ndings which have indicated that in keratinocytes, in contrast to hematopoietic cell lines, IL-4 also induced ERK activation (Wery et al., 1996) . In A431 cells, we and others have demonstrated that the nature of the IL-4R is dierent from hematopoietic cell lines (Murata et al., 1997; Wery-Zennaro et al., 1999) . The characterization of IL-4R, reported in a larger number of cell lines, indicated that only hematopoietic cells signi®cantly expressed g c . This dierence of the nature of the receptor between hematopoietic and non hematopoietic cell lines could explain why MAPK cascade as ERK and p38 MAPK could be activated in response to IL-4 in A431 cells. The p38 MAPK protein is an important mediator of stress-induced gene expression (Davis, 1995) . In particular, the p38 MAPK is known to play a key role in LPS induced signal transduction pathway leading to cytokine synthesis (Lee et al., 1994; Lee and Young, 1996) . Previous studies indicate that p38 MAPK functions regulate processes that control translation of cytokine mRNA (Prichett et al., 1995; Young et al., 1993) . Other studies indicate that p38 MAPK can function at the transcription level in the case of IL-1b and TNFa genes (Baldassare et al., 1999; Beyaert et al., 1996; Vanden Berghe et al., 1998) . Indeed, several transcription factors, such as ATF-2, MEF-2C and CHOP-1, have been described to be phosphorylated by p38 MAPK Raingeaud et al., 1995; Wang and Ron, 1996) . The use of a speci®c inhibitor of p38 MAPK SB203580 suggests that other transcription factors such as (C/EBP)/NFIL-6 (Baldassare et al., 1999) , STAT1, STAT3 (Gollob et al., 1999) and NF-kB (Vanden Berghe et al., 1998) are also targets for p38 MAPK.
In our model, we noted that a speci®c inhibitor of p38 MAPK, SB203580, abolished the IL-6 expression induced by IL-4, indicating that p38 MAPK might be involved in this regulation. EMSA analysis using IL-6 promoter indicated that IL-6 only stimulates the activation of STAT6. We did not observe any modi®cation of binding of transcriptional factors previously described as targets for p38 MAPK. However, the activation of STAT6 is not sucient to increase the proximal IL-6 promoter-driven luciferase expression in transfected cells.
Our results indicated that no IL-6 mRNA is detected in unstimulated cells. After IL-4 stimulation, we observed a marked increase of IL-6 mRNA expression. Thus, we cannot exclude that a transcriptional regulation of IL-6 mRNA occurs after IL-4 stimulation, but outside the proximal IL-6 promoter region we used in the transfection experiments. While much of the understanding of the transcriptional regulation of genes derives from studies of gene promoters, it is clear that regulation of transcription in eukaryotes occurs at multiple levels.
Elements such as enhancers or repressors regulate promoter activity in a position-and orientationindependent fashion and can act at a considerable distance from the promoter (Ernst and Smale, 1995) . Such regulation has been described for several genes and, in particular, for IL-3 and GM-CSF genes. Elements located 14 kb and 3 kb upstream IL-3 and GM-CSF genes respectively have been identi®ed as distal enhancers (Cockerill et al., 1993; Dunclie et al., 1997) . An additional level of transcriptional regulation has been described for the Keratin 18 gene, where the regulatory element upstream of K18 proximal promoter can cooperate with a regulatory element localized in the ®rst intron and exon 6. This provides multiple opportunities for activating transcription in diverse tissues (Rhodes and Oshima, 1998) . Although, to our knowledge, this mechanism of transcriptional regulation has not been yet described for IL-6 gene, we cannot exclude that it could occur in A431 cells in response to IL-4.
Another level of complexity is added by the observation that IL-1 stabilizes also the mRNA of IL-6 gene (Elias and Lentz, 1990; Miyazawa et al., 1998; Ng et al., 1994) . In the present study, we give evidence that the inhibition of p38 MAPK activity signi®cantly reduced stability of the IL-6 mRNA. Furthermore we found that the ERK pathway was not implicated in this regulation. AU-rich sequences have been identi®ed as crucial cis element mediating RNA instability. It was reported that a p38 MAPK inhibitor suppress TNFa synthesis without aecting the mRNA level (Lee et al., 1994; Prichett et al., 1995) probably at the translational level through AU rich elements in its untranslated regions. Repeated AUUUA sequences in the 3' untranslated region of many protooncogene and cytokines mRNA are not only the target for rapid degradation (Caput et al., 1986; Chen and Shyu, 1995; Shaw and Kamen, 1986) but also suppress the translation of the corresponding mRNA (Kruys and Huez, 1994; Kruys et al., 1989) . IL-6 mRNA contains six copies of the AUUUA sequence in its 3'-untranslated region (Hirano et al., 1986) . There is a possibility that IL-4-stimulated p38 MAPK or some downstream kinases may in¯uence the proteins that bind to the AUUUA sequences of IL-6 mRNA, resulting in mRNA stabilization. Indeed, several molecules such as AUF1 and TIAR bind AUrich sequences to reduce mRNA stability (DeMaria and Brewer, 1996; Gueydan et al., 1999) . In addition the formation of the AUUUA sequence-binding complex and the accelerated mRNA turnover are dependent on phosphorylation (Sirenko et al., 1997 ). An alternative control of IL-6 expression could be also at the translational level. In fact, the phosphoprotein elF4E binds to the 7-methylguanosine triphosphatè cap' to initiate translation. The phosphorylation of elF4E is enhanced by agents such as certain stresses and cytokines that activate p38 and this is blocked by a speci®c inhibitor of this enzyme (Wang et al., 1998) . In summary, the results give new insight into the contribution of p38 MAPK pathway to IL-4 induced IL-6 gene regulation in keratinocytes.
Materials and methods
Cell culture
The A431 keratinocytic cell line was cultured in DMEM supplemented with antibiotics (50 mg/ml penicillin, 50 mg/ml streptomycin), with 2 mM glutamine and with 10% FCS. Human recombinant IL-4 was a generous gift of N Vita (Sano®, France) and was added to the culture media at a ®nal concentration of 50 ng/ml.
In vitro kinase assays MAPK assays Serum starved cells were stimulated with IL-4 for dierent periods of time and lysed in 200 ml of cell extract buer (25 mM HEPES, pH 7.7, 0.3 M NaCl 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.1% Triton X-100, 20 mM bglycerophosphate, 0.1 mM Na 3 VO 4 , 10 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml pepstatin, 1 mM PMSF). Extracts were then rotated for 30 min at 48C. After centrifugation, the supernatant was diluted with 600 ml of dilution buer (20 mM HEPES pH 7.7, 2.5 mM MgCl 2 , 0.1 mM EDTA, 0.05% Triton X-100, 20 mM b-glycerophosphate, 0.1 mM Na 3 VO 4 , 10 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml pepstatin, 1 mM PMSF), incubated for 10 min on ice, and centrifuged again. Lysates were then mixed with GST fusion protein kinase substrates (2.5 mg of each, as indicated) and gluthathione-sepharose (15 ml, Amersham) and incubated at 48C overnight. Experiments were carried out as described (Ruckdeschel et al., 1997) with two dierent GST fusion protein kinase substrates obtained from M Karin (GST-c-jun (1 ± 222), and B DeÂ ridjard (GST-ATF-2). After pull-down, beads were washed four times with binding buer (20 mM HEPES, pH 7.7, 50 mM NaCl, 25 mM MgCl 2 , 0.1 mM EDTA, 0.05% Triton X-100), and in vitro phosphorylation was carried out for at 308C for 20 min in 30 ml of kinase buer containing, 20 mM HEPES, pH 7.6, 20 mM MgCl 2 , 20 mM b-glycerophosphate, 0.1 mM Na 3 VO 4 , 2 mM DTT, 20 mM p-nitrophenylphosphate, 20 mM ATP (4 mCi of [g-32 P]ATP). The reaction was stopped by adding 30 ml of 26Laemmli sample buer. Proteins were fractionated by a 10% SDS ± PAGE, subjected to autoradiography and quanti®ed with a phospho¯uorimager (Molecular Dynamics, Inc).
PAK kinase assay Cell lysates were prepared as described for MAPK assays. Rabbit polyclonal anti-PAK1 antibody was added to 500 mg of cell lysates (500 ml) and rotated overnight at 48C. Immunecomplexes were recovered by protein A sepharose. The precipitates were washed twice with binding buer (see above), once with binding buer containing 0.5 M NaCl and twice with binding buer. Immunecomplex kinase assays were performed at 308C for 30 min using 35 ml of kinase buer (see above) and 2.5 mg of MBP as kinase substrate. The reaction was stopped by adding 30 ml of 26Laemmli sample buer. Proteins were separated by a 10% SDS ± PAGE, followed by autoradiography.
Affinity precipitation of Rac-GTP and Cdc42-GTP using GST-CRIB from PAK and WASP cDNA for an extended Cdc42/Rac interactive binding (CRIB) domain from WASP (amino acids 201 ± 321) (Rudolph et al., 1998) was ampli®ed by PCR using appropriate oligonucleotides and cloned into pGEX4T1 (Amersham-Pharmacia Biotech Inc.). The GST-CRIB of PAK, was kindly provided by Dr PN Lowe (Glaxo Welcome, UK).
A431 cells were washed with ice cold Tris-buer saline and lysed in RIPA buer as described (Ren et al., 1999) . Cell lysates were clari®ed by centrifugation at 15 000 r.p.m. for 15 min at 48C, and 4 mg protein from total lysates were incubated at 48C for 45 min with 50 mg GST-CRIB immobilized on glutathione beads. The beads were washed four times with Tris buer containing (1% Triton X-100, 150 mM NaCl, 10 mM MgCl 2 , 10 mg/ml leupeptin, 10 mg/ml aprotinin, and 0.1 mM PMSF). Proteins were separated by 12.5% SDS ± PAGE followed by blotting onto PVDF membranes. Bound Rac/Cdc42 proteins were detected using polyclonal antibody against Rac and Cdc42 respectively (Lang et al., 1993) , immunoreactive bands were visualized using horseradish peroxidase-conjugated antirabbit IgG and subsequent ECL detection reagents (Amersham-Pharmacia).
Western blotting
Cells were lysed in a RIPA buer and the cell lysate was clari®ed by centrifugation. One hundred mg of total protein were resolved on SDS ± PAGE, and electrophoretically transferred to PVDF membranes. The blot was then hybridized with anti-P-Tyr 4G10 (Upstate Biotechnology Inc.).
Electrophorectic mobility shift assay A431 cells were scrapped into PBS containing 1 mM Na 3 VO 4 and pelleted. The hypotonic buer (20 mM HEPES, pH 7.9, 1 mM Na 3 VO 4 , 1 mM NaPP, 0.125 mM okadaic acid, 0.2% NP40, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.5 mM PMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin) supplemented with 0.2% NP40, was added directly on the pellet and mixed. Nuclei were pelleted (16 000 g, 20 s). The nuclear pellets were then resuspended into a high salt buer (20 mM HEPES, pH 7.9, 1 mM Na 3 VO 4 , 1 mM sodium pyrophosphate, 0.125 mM okadaic acid, 0.2% NP40, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.5 mM PMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin, 0.42 M NaCl, 20% glycerol) and gently rocked for 3 min at 48C. Extracted proteins were separated from residual nuclei (16 000 g, 20 min).
For the binding reaction, nuclear extracts (15 mg of protein) were diluted up to a ®nal volume of 20 ml containing 20 mM HEPES, pH 7.5, 40 mM KCl, 2.5 mM MgCl 2 , 3 mM EDTA Na 2 , 1 m MDTT, 10% glycerol, and 1 mg of polydl/dC. Oligonucleotides ( Figure 4) were annealed, radiolabeled with T4 polynucleotide kinase and [g-32 P]ATP and puri®ed by ethanol precipitation. Oligonucleotide (100 pg, 20 000 c.p.m.) was added to the reaction mixture followed by incubation 1 h at room temperature. The protein-DNA complexes were separated by electrophoresis through a non denaturating 4.5% polyacrylamide gel in 0.56TBE at 48C. The gel was then dried and followed by autoradiography. For supershift analysis, 15 mg of nuclear extracts were preincubated 1 h at 208C with 1 mg of indicated antibodies before addition of 32 P-labeled probe.
Quantification of IL-6
IL-6 was measured by a sandwich enzyme-linked immunoabsorbent assay using ELISA kit from Diaclone, France, according to the manufacturer instructions. The absorbance at 450 nm was measured by a microplate reader. The lower limit of detection of the assay was 3 pg/ml.
RNAse protection assays
IL-6 speci®c sequence was ampli®ed by RT ± PCR, using oligonucleotides: 5'-AGCTGAATTCTCAATGAGGAGAC-TTGCCTG (sense) and 5'-AGCTGGATCCGATGAGTTGT-CATGTCCTGC (antisense) and cloned into PGEM3Z (Promega). SP6 polymerase was used to generate antisense transcripts that were used as probes for RNAse protection assays.
A431 cells were preincubated or not 1 h with either 10 mM SB203580, 10 mM SB202474 or 50 mM PD098059 and then stimulated with IL-4 for the indicated time. For mRNA stability study, cells were stimulated with IL-4 for 5 h in the presence or not of the dierent drugs and subsequently incubated with actinomycin D (10 mg/ml) for 15, 30 or 60 min. Total RNA was prepared by Trizol (Gibco) using the manufacturer instruction and analysed by RNAse protection. 32 P-labeled probes for RNase protection were obtained by in vitro transcription. Total RNA (10 mg) was denaturated for 10 min at 858C with 1 ng of internally 32 P-labeled probe, in 80% deionized formamide, 40 mM PIPES pH 6.7, 0.4 M NaCl, 1 mM EDTA. Annealing was performed overnight in 30 ml at 458C. Digestion was done by addition of 300 ml of p38 MAP kinase and IL-6 gene expression S Wery-Zennaro et al digestion cocktail (10 mg/ml RNAse A; 10 3 U/ml of RNase T1, 10 mM Tris-HCl pH 8, 0.3 M NaCl, 5 mM EDTA) at 378C for 1 h. Reactions were stopped by adding 20 ml of 20% SDS and 10 mg of proteinase K at 378C for 15 min. RNA were extracted by phenol-chloroform, precipitated with ethanol, resuspended in loading buer (80% formamide, 10 mM EDTA pH 8, 1 mg/ml xylen cyanol, 1 mg/ml bromophenol blue), heated 3 min at 908C and loaded on 5% sequencing gel.
Abbreviations AMV, avian myeloblastosis virus; AP-1, activator protein; ARE, AU rich element; ATF-2, activating transcription factor; C/EBP, CCAAT/enhancer binding protein; CRIB, Cdc42/Rac interacting binding; EGF, epidermal growth factor; EMSA, electrophoretic mobility shift assay; ERK, extracellular regulated kinase; IL, interleukin; IL-4R, IL-4 receptor; IRS, insulin receptor substrate; JAK, janus kinase; JNK, C-jun N terminal kinase; LPS, lipopolysaccharide; MAP, mitogen activated protein; NF-kB, nuclear factor; PAGE, polyacrylamide gel electrophoresis; PAK, p21 activated kinase; Rb, retinoblastoma; RBP-Jk, recombination signal-sequence binding protein; RT ± PCR, reverse transcriptase polynucleotide chain reaction; SAPK, stress activated protein kinase; SH2, src-homology 2; STAT, signal transducer and activator of transcription; TNF, transforming necrosis factor; UTR, untranslated region; WASP, Wiscott Aldrich Syndrome protein
